ELANCO AH0351 OESTRADIOL COMPUDOSE 100

Land: Australië

Taal: Engels

Bron: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Koop het nu

Bijsluiter Bijsluiter (PIL)
19-06-2017
Productkenmerken Productkenmerken (SPC)
19-06-2017

Werkstoffen:

OESTRADIOL 17 BETA

Beschikbaar vanaf:

ELANCO AUSTRALASIA PTY LTD

INN (Algemene Internationale Benaming):

oestradiol(21.1mg/Ds)

farmaceutische vorm:

PARENTERAL IMPLANT, DEVICE

Samenstelling:

OESTRADIOL 17 BETA STEROID-ESTROGEN Active 21.1 mg/do

Eenheden in pakket:

%(10x10); %100 Impls; %Impls; 10 Impls; 20 Impls; 5x20 Impls

klasse:

VM - Veterinary Medicine

Geproduceerd door:

ELANCO ANIMAL HEALTH

Therapeutische categorie:

HEIFER (YOUNG FEMALE CATTLE) | HEIFER SPEYED (NEUTERED YOUNG COW) | STEER (CASTRATED MALE CATTLE) | BEEF | BOVINE | BULLOCK (YOU

Therapeutisch gebied:

NUTRITION & METABOLISM

therapeutische indicaties:

PROMOTE ANIMAL GROWTH | FEED CONVERSION | FINISHING | GROWTH PROMOTION | GROWTH RATE | LIVEWEIGHT GAIN

Product samenvatting:

Poison schedule: 5; Withholding period: WHP: meat - nil milk-DO NOT use in heif ers which are producing or may in the f uture produce milk or milk products for human consumption.; Host/pest details: HEIFER (YOUNG FEMALE CATTLE): [PROMOTE ANIMAL GROWTH]; HEIFER SPEYED (NEUTERED YOUNG COW): [PROMOTE ANIMAL GROWTH]; STEER (CASTRATED MALE CATTLE): [PROMOTE ANIMAL GROWTH]; Growth Promotant Implants for steers, spayed heifers and vealer heifers.For use only in steers & heifers. DO NOT USE in any other species of animals. Must only be supplied in accordance with Div.2 part 4 of the Agvet Regulations (Supply of Hormonal Growth Promotants). See RESTRAINTS/PRECAUTIONS on label also.

Autorisatie-status:

Registered

Autorisatie datum:

2023-07-01

Bijsluiter

                                CAUTION
ACTIVE CONSTITUENT:
21.1 mg OESTRADIOL 17ß per dose.
READ THE ENCLOSED LEAFLET
BEFORE USING THIS PRODUCT.
WITHHOLDING PERIOD:
MEAT – NIL
MILK – DO NOT USE IN HEIFERS WHICH
ARE PRODUCING OR MAY IN THE FUTURE
PRODUCE MILK OR MILK PRODUCTS FOR
HUMAN CONSUMPTION.
MADE IN U.S.A.
APVMA Approval No: 46230/10/0306
ELANCO ANIMAL HEALTH.
A division of Eli Lilly Australia Pty. Ltd.
10 Implants
FL0010DEALB (V01-05-2006) 04 61 20 00
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
AH0351
Exp.
[B]
OESTRADIOL
COMPUDOSE
®
100
Store below 30°C (Room Temperature)
PPL = 100% MPL = 30 MM X 65 MM (THIS TEXT IS NOT TO BE PRINTED)
APPROVED
LABEL
Info
PEST

Verified
SH8070DEALS (V01-05-2006)
COMPUDOSE
®
100
OESTRADIOL
COMPUDOSE
®
100
OESTRADIOL
AH0351
AH0351
CAUTION
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
10 X 10 IMPLANTS
ACTIVE CONSTITUENT: 21.1 mg OESTRADIOL 17ß per dose.
THIS IMPLANT IS PALPABLE. THIS PRODUCT MUST ONLY BE SUPPLIED IN
ACCORDANCE WITH DIVISION 2 PART 4 OF THE AGVET REGULATIONS
(SUPPLY OF HORMONAL GROWTH PROMOTANTS)
Growth Promotant Implants for Steers, Spayed Heifers and
Vealer Heifers.
For subcutaneous ear implantation only.
ELANCO ANIMAL HEALTH
A DIVISION OF ELI LILLY AUSTRALIA PTY. LTD.
A.B.N. 39 000 233 992
112 WHARF ROAD, WEST RYDE, NSW 2114
Tel: Toll Free 1800 226 324
DIRECTIONS FOR USE:
USE ONLY in accordance with the instructions on this label unless
authorised under appropriate legislation.
RESTRAINTS
FOR USE ONLY IN STEERS, SPAYED HEIFERS AND VEALER HEIFERS PRODUCING
BEEF FOR HUMAN CONSUMPTION.
DO NOT USE IN HEIFERS WHICH ARE PRODUCING OR MAY IN THE FUTURE PRODUCE
MILK OR MILK PRODUCTS FOR
HUMAN CONSUMPTION. DO NOT USE THIS PRODUCT IN ANY OTHER SPECIES OF
ANIMAL.
IMPLANT ONLY BENEATH THE SKIN IN THE MIDDLE THIRD OF THE EAR. DO NOT
IMPLANT THIS PRODUCT IN ANY
OTHER SITE.
INSERT ONLY ONE IMPLANT EVERY 100 DAYS AS DIRECTED IN THE ENCLOSED
LEAFLET.
IT IS A BREACH OF AQIS ACCREDITATION CONDITIONS TO USE THIS PRODUCT ON
HGP FREE ACCREDITED CATTLE OR
TO POSSESS THIS PRODUCT 
                                
                                Lees het volledige document
                                
                            

Productkenmerken

                                Issue date: 15-September-2015
Version number: 01
SAFETY DATA SHEET
1. Identification
Elanco AH0351 Oestradiol Compudose 100
Product identifier
Other means of identification
Estra-1,3,5(10)-triene-3,17-diol (17beta)- * Shur-Gain * 033636
Formulation * Controlled Release
Implant * Estradiol Implants * Compudose 100 * Encore * Compudose 400
* Compudose 200
Synonyms
AH0320, AH0323, AH0327, AH0340, AH0343, AH0347, AH0351, AH0370,
AH0373, AH0918,
AH0919, QA330A, SI6480, UC5190, UC5199
Item Code
Recommended use of the chemical and restrictions on use
Veterinary Pharmaceutical
Recommended use
Not available.
Restrictions on use
Details of manufacturer or importer
Manufacturer
Company name
Elanco Animal Health
A Division of Eli Lilly Australia Pty Ltd
Address
A.B.N. 39 000 233 992
112 Wharf Road, West Ryde, N.S.W. 2114, Australia
Telephone
(02) 9878 7777
Fax
(02) 9878 7720
e-mail
lilly_msds@lilly.com
Emergency phone
number
Elanco Animal Health: 1800 226 324 (Toll free)
OR Poisons Information Centre: 131126 (Australia-wide)
24 hr emergency contact
number
CHEMWATCH 1800 039 008 (spills and accidents)
24 hr emergency contact
number (Local)
CHEMWATCH +61 2 9186 1132 (spills and accidents)
2. Hazard(s) identification
Classification of the hazardous chemical
Not classified.
Physical hazards
Category 1A
Carcinogenicity
Health hazards
Category 1A
Reproductive toxicity
Effects on or via lactation
Reproductive toxicity
Category 2
Hazardous to the aquatic environment, acute
hazard
Environmental hazards
Category 2
Hazardous to the aquatic environment,
long-term hazard
Label elements, including precautionary statements
Hazard symbol(s)
Health hazard Environment
Signal word
Danger
Hazard Statement(s)
May cause cancer. May damage fertility or the unborn child. May cause
harm to breast-fed
children. Toxic to aquatic life with long lasting effects.
1 / 10
Material name: Elanco AH0351 Oestradiol Compudose 100
4827
SDS AUSTRALIA
Precautionary Statement(s)
Prevention
Obtain special instructions before use. Do not handle until all safety
preca
                                
                                Lees het volledige document